Amova Asset Management Americas, Inc.
Position in CRSP — CRISPR Therapeutics AG
CIK 1480751
NEW YORK, NY
Position in CRSP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$93,814,090
+$5,625,257 QoQ
Shares Held
1,720,097
-7.2% QoQ
Ownership
1.78%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#13
of 519 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Amova Asset Management Americas, Inc. holds $354,236,903 across 20 Biotechnology names. CRSP ranks #2 (26.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BEAM |
Beam Therapeutics Inc.
|
3,455,043 | $118,577,075 | |
| 2 | CRSP |
CRISPR Therapeutics AG
This page
|
1,720,097 | $93,814,090 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
2,897,529 | $49,026,190 | |
| 4 | NRIX |
Nurix Therapeutics, Inc.
|
983,462 | $23,858,788 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
5,511,687 | $20,227,891 | |
| 6 | ARCT |
Arcturus Therapeutics Holdings Inc.
|
1,960,458 | $13,174,277 | |
| 7 | ABSI |
Absci Corp
|
1,013,965 | $11,751,854 | |
| 8 | PRME |
Prime Medicine, Inc.
|
2,407,018 | $8,881,896 |
All Filings in CRSP
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93,814,090 | 1,720,097 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $88,188,833 | 1,853,875 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $102,683,340 | 1,958,111 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $140,227,776 | 2,163,675 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $117,430,141 | 2,414,271 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $86,432,422 | 2,539,889 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $108,069,807 | 2,745,676 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $139,399,948 | 2,967,219 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $170,213,271 | 3,151,514 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $222,800,385 | 3,268,785 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $210,947,101 | 3,369,762 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $157,297,683 | 3,465,470 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $198,362,661 | 3,533,357 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $179,659,846 | 3,972,139 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $162,863,249 | 4,006,476 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $278,569,797 | 4,262,736 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $278,575,635 | 4,584,098 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $289,981,519 | 4,619,747 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $327,329,512 | 4,319,471 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $368,195,525 | 3,289,516 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $547,747,691 | 3,383,456 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $445,954,550 | 3,659,865 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $587,455,969 | 3,836,823 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $309,272,867 | 3,697,667 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $272,792,675 | 3,711,970 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $159,739,003 | 3,766,541 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||